ArticleBMJ open2023

Postmarketing observational study on the safety of 2021/2022 and 2022/2023 influenza vaccination campaigns in Italy: TheShinISS-Vax|Flu study protocol.

Stefania Spila Alegiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.